期刊文献+

多中心特异性MICA抗体的检测结果及临床应用价值分析 被引量:1

The analysis of anti-major histocompatibility complex class I -related chain A(MICA) specific antibodies testing results in muiticenter and its clinical applications
原文传递
导出
摘要 目的对比3种人主要组织相容性复合物I类相关链A位点(MICA)特异性抗体检测试剂结果的一致性,预测其临床推广应用的价值。方法18家实验室参加16届国际组织相容性和免疫协作组,均采用免疫磁珠流式细胞仪液相芯片技术检测4批16份血清样本的MICA抗体的特异性,3种试剂标记为Kit-A、Kit-B、Kit-C。结果在16份血清样本中,804为阴性,15份样本结果阳性,其中S10样本各实验室均上报为阳性。依据MICA抗原公共表位分G1(MICA 01、02、07、12、17、18)组和G2(MICA04、06、08/27、09、19)组,5例样本用Kit—A和Kit-B均能判别MICA-G1组特异性抗体,Kit-C存在MICA08/27和MICA19的假阳性结果。5例样本用Kit—A和Kit-B均能判别MICA-G2组特异性抗体。其余5例样本用Kit-A、Kit—B和Kit-C均无法判别MICA特异性抗体一致的结果。从3种试剂均能判别10种MICA特异性抗体结果分析,MICA08/27(86.67%,13/15)抗体结果一致性最高,MICA19(40%,6/15)一致性最低。使用Kit—B试剂的实验室间有13例MICA特异性抗体样本结果符合率大于80%。结论协作组实验室对于判断MICA抗体阴性或阳性没有差异,而对MICA抗体特异性分析存在不一致性,因此,建议选择MICA特异性抗体类型较宽检测试剂或最好选择两种以上的试剂进行检测。 Objective To research the consistency of testing results with three different anti- major histocompatibility complex class I -related chain A(MICA) specific antibody reagents in order to evaluate their clinical application's value. Method An collaborative study of 18 laboratories was undertaken at the 16th International HLA and Immunogenetics Workshop. Total of 16 sera(4 batchs) were tested for anti-MICA antibodies by Luminex method with three different reagents (Kit-A, -B and -C). Result Anti-MICA antibodies were found in 15 sera, except one sera(no. S04) ; No. S]0 sera showed positive results in all the laboratories. The anti-MICA antibodies were divided into MICA-G1 group (MICA01, 02, 07, 12, 17 and 18) and MICA-G2 group (MICA 04, 06, 08/27, 09 and 19). MICA-G1 group specific antibodies were detected in 5 sera with Kit-A and -B reagent but there were false-positive results of anti-MICA08/27 and MICA19 antibodies in this 5 sera with KivC. MICA-G2 group specific antibodies can be detected in other 5 sera with Kit-A and -B, But the MICA specific antibodies testing gave different results with Kit-A, -B and -C in all the last 5 sera samples. Testing of MICA08/27 showed highest consistency results (86. 67~, 13/15) with Ki^A, -B and C; and testing of MICA19 showed lowest consistency results (40%, 6/15) with this 3 reagents. There were 80O//oo consistency results of anti-MICA specific antibodies in 13 sera with Kit 13. Conclusion There are the same effect to judgment positive or negative result for anti-MICA antibodies with 3 different reagents,but the results of anti-MICA specific antibodies are not the same. Therefore, it's better to use two or more reagents to test anti-MICA specific antibodies, or choose reagent with wide detection range.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2014年第5期290-294,共5页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金(81273266,30872530) 卫生部重大科研基金(LW201002) 江苏省医学创新团队与领军人才(LJ201138) 江苏省医学重点学科(XK201151) 江苏省科技支撑计划项目(BE2010651) 江苏省临床医学中心(ZX201102) 苏州市科技基础设施建设计划项目(SZS201001,szS0702)
关键词 器官移植 主要组织相容性复合物 抗供者特异性抗体 基因 抗原表位 Organ transplantation Major histocompatibility complex Donor specific antibody Gene Epitopes
  • 相关文献

参考文献16

  • 1Zou Y, Stastny P, Stisal C, et al. Antibodies against MICA antigens and kidney-transplant rejection[J]. N Engl J Med, 2007, 357(13) : 1293-1300.
  • 2Zou Y, Qin Z, Silveus A, et al. Polymorphisms of MICA recognized by human alloantibodies [J]. Immunogeneties, 2009, 61 (2) 91-100.
  • 3侯建全,何军,袁晓妮,王乾,王云炎,李强,张江磊,李琛,鲍晓晶,邱桥成,李扬,温端改.抗HLA和抗MICA抗体的表达对移植肾功能和急性排斥反应的预示作用[J].中华器官移植杂志,2010(6):343-347. 被引量:6
  • 4Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities [ J ]. Transplantation, 2003, 75 (1) : 43-49.
  • 5Zou Y, Heinemann FM, Grosse-Wilde H, et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and ineluates from rejected kidney allografts by Luminex flow cytometry[J]. Hum Immunol, 2006, 67(3):230-237.
  • 6Duquesnoy RJ, Mostecki J, Hariharan J, et al. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns [J]. Hum Immunol, 2008, 69(12):826-832.
  • 7Duquesnoy RJ. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications [J]. Tissue Antigens, 2011, 77(6) :525-534.
  • 8Mizutani K, Terasaki P, Rosen A, et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure[J]. Am J Transplant, 2005, 5 (9) :2265- 2272.
  • 9Mizutani K, Terasaki P, Bignon JD, et al. Association of kidney transplant failure and antibodies against MICA[J]. Hum Immunol, 2006, 67(9) :683-691.
  • 10Cox ST, Stephens HA, Fernando R, et al. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation [J]. Hum Immunol, 2011, 72(10) :827-834.

二级参考文献10

  • 1Karahan GE, Seyhun Y, Oguz F, et al. Anti-HLA antibody profile of Turkish patients with end-stage renal disease. Transplant Proe,2009,41 (9) :3651-3654.
  • 2Lee PC, Zhu L, Terasaki PI, et al. HI.A-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplant ation,2009,88 (4):568- 574.
  • 3Zielinska H, Zielinski M, Moszkowska G, et al. Diagnostic value of specific anty-HLA alloantibodies before and after renal transplantation. Programs for highly sensitized recipients. Postepy Hig Med Dosw (Online),, 2009,63 : 435-448.
  • 4Kosmoliaptsis V,Chaudhry AN, Sharpies LD, et al. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation, 2009,88 (6) : 791- 798.
  • 5Gill JS,Landsberg D, Johnston O, et al. Screening for de novo anti human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation, 2010, 89(2): 178-184.
  • 6Lachmann N, Terasaki PI, Budde K, et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation, 2009, 87 ( 10) 1505-1513.
  • 7Loupy A, Suberbielle BoisseI C, Hill GS, et al. Outcome of subclinical antibody mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant,2009,9(11 ) :2561- 2570.
  • 8Einecke G, Sis B, Reeve J, et al. Antibody mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant, 2009,9 ( 11 ) : 2520- 2531.
  • 9Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d negative antibody- mediated rejection. Curr Opin Organ Transplant, 2010,15 ( 1 ) : 42-48.
  • 10Nath DS, Basha HI, Mohanakumar T. Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection. Curr Opin Organ Transplant, 2010,15 ( 1 ) : 16 -20.

共引文献5

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部